The Company's calculation of basic earnings (loss) per share ("EPS") and diluted EPS is described in Note 16, Earnings Per Share, to the Company's consolidated financial statements in the 2025 Form 10-K.


	Three Months Ended February 28,				Six Months Ended February 28,
(in thousands, except share and per share data)	2026		2025		2026		2025
Net earnings (loss)	$	93,032	$	25,473	$	270,314	$	(150,245)

Average basic shares outstanding	110,960,062		113,564,436		111,014,543		113,811,675
Effect of dilutive securities	957,892		945,857		1,139,736		—
Average diluted shares outstanding	111,917,954		114,510,293		112,154,279		113,811,675

Earnings (loss) per share:
Basic	$	0.84	$	0.22	$	2.43	$	(1.32)
Diluted	0.83		0.22		2.41		(1.32)

For all periods presented except for the six months ended February 28, 2025, the Company had immaterial anti-dilutive shares, which were not included in the computation of average diluted shares outstanding. For the six months ended February 28, 2025, the Company had 1,270,113 shares that were excluded from the computation of average diluted shares outstanding due to the Company's net loss position.

During the three and six months ended February 28, 2026, the Company repurchased 249,154 and 912,374 shares of CMC common stock, respectively, at an average purchase price of $73.46 and $62.70 per share, respectively. Under the share repurchase program, the Company had remaining authorization to repurchase $147.8 million of shares of CMC common stock as of February 28, 2026. See Note 15, Capital Stock, to the Company's consolidated financial statements in the 2025 Form 10-K, for more information on the share repurchase program.